Ikena Oncology, Inc.
USD17.16
+15.79 (+1152.55%)
CEO
Mark Manfredi
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.38
Prev. Close
$1.37
Day Low
$1.36
Day High
$17.16
52W Low
$1.36
52W High
$23.28
Market Cap
$0.72B
Volume
0.46M
| -26.0 |
| 31 Dec 2023 | FY | 88.9% | -744.2% | -40.2% | -35.5% | 0.06 | 12.58 | -14.5 |
| 31 Dec 2022 | FY | -311.8% | -440.3% | -46.8% | -39.9% | 0.04 | 7.44 | -16.8 |
| 31 Dec 2021 | FY | -52.0% | -110.1% | -16.4% | -13.8% | 0.03 | 8.70 | -158.7 |
| 31 Dec 2020 | FY | -387.8% | -481.4% | 43.8% | -26.3% | -0.00 | 5.86 | -121.4 |
| 31 Dec 2019 | FY | -81.3% | -122.3% | 27.4% | -19.6% | 0.00 | 3.51 | -818.6 |
| 31 Dec 2018 | FY | -3838.0% | -4127.8% | 89.1% | -197.6% | -1.37 | 5.22 | -336.9 |
| -2.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -17.7% | -15.4% | 0.08 | 13.24 | -0.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -2.4% | -2.2% | 0.05 | 13.52 | -70.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -7.3% | -6.6% | 0.06 | 13.31 | -21.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -7.2% | -6.4% | 0.06 | 11.80 | -26.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -7.6% | -6.9% | 0.06 | 15.32 | -24.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -9.6% | -8.7% | 0.06 | 18.22 | -17.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -10.4% | -9.3% | 0.06 | 15.85 | -12.5 |
| 31 Dec 2023 | Q4 | 53.7% | -2957.4% | -11.5% | -10.1% | 0.06 | 12.58 | -14.5 |